1. Home
  2. EXEL vs DOGZ Comparison

EXEL vs DOGZ Comparison

Compare EXEL & DOGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • DOGZ
  • Stock Information
  • Founded
  • EXEL 1994
  • DOGZ 2003
  • Country
  • EXEL United States
  • DOGZ China
  • Employees
  • EXEL N/A
  • DOGZ N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • DOGZ Miscellaneous manufacturing industries
  • Sector
  • EXEL Health Care
  • DOGZ Consumer Discretionary
  • Exchange
  • EXEL Nasdaq
  • DOGZ Nasdaq
  • Market Cap
  • EXEL 11.3B
  • DOGZ 399.0M
  • IPO Year
  • EXEL 2000
  • DOGZ 2017
  • Fundamental
  • Price
  • EXEL $43.30
  • DOGZ $9.10
  • Analyst Decision
  • EXEL Buy
  • DOGZ
  • Analyst Count
  • EXEL 18
  • DOGZ 0
  • Target Price
  • EXEL $43.00
  • DOGZ N/A
  • AVG Volume (30 Days)
  • EXEL 3.8M
  • DOGZ 467.6K
  • Earning Date
  • EXEL 08-05-2025
  • DOGZ 03-31-2025
  • Dividend Yield
  • EXEL N/A
  • DOGZ N/A
  • EPS Growth
  • EXEL 237.58
  • DOGZ N/A
  • EPS
  • EXEL 2.20
  • DOGZ N/A
  • Revenue
  • EXEL $2,298,922,000.00
  • DOGZ $20,258,926.00
  • Revenue This Year
  • EXEL $9.37
  • DOGZ N/A
  • Revenue Next Year
  • EXEL $11.05
  • DOGZ N/A
  • P/E Ratio
  • EXEL $19.74
  • DOGZ N/A
  • Revenue Growth
  • EXEL 24.49
  • DOGZ 46.16
  • 52 Week Low
  • EXEL $21.86
  • DOGZ $8.64
  • 52 Week High
  • EXEL $49.62
  • DOGZ $58.50
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 52.67
  • DOGZ 21.96
  • Support Level
  • EXEL $43.39
  • DOGZ $8.64
  • Resistance Level
  • EXEL $48.74
  • DOGZ $10.58
  • Average True Range (ATR)
  • EXEL 2.00
  • DOGZ 3.11
  • MACD
  • EXEL -0.01
  • DOGZ -2.21
  • Stochastic Oscillator
  • EXEL 38.49
  • DOGZ 2.01

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

Share on Social Networks: